[1]
Muttaqin, F.Z., Ramadhanty, H., Muhammad, H.N. and Musfiroh, I. 2022. Inhibiting Adenosine A2A Receptors as a Treatment for Parkinson’s Disease. SIGn Journal of Pharmacy. 1, 1 (May 2022), 1-5. DOI:https://doi.org/10.37276/sjp.v1i1.140.